PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
(PLANO, TX – April 2, 2020) – Today, Pharmaceutical Strategies Group (PSG) announced that MJH Life Sciences™ has acquired the Pharmacy Benefit Management Institute (PBMI),…
Coronavirus likely to sideline 2020 policy changes for prescription pricing and 340B, while Medicare Part B reimbursement changes continue as planned The coronavirus (COVID-19) outbreak…
PLANO, TX – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health plans…
PLANO, Texas – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health plans…
PLANO, Texas – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health plans…
Plan sponsors are concerned about the turbulence in the prescription drug marketplace, particularly the recent alliances between major PBMs and insurers. Since …
The third annual State of Specialty Spend and Trend Report analyzes specialty drug utilization and spending across 36 million pharmacy claims and 73 million medical…
The Big Three Pharmacy Benefit Managers (OptumRx, Express Scripts, CVS Caremark) released updates to their 2020 formulary exclusions, and our analysis shows that member impact…
With drug costs continually escalating, health plans need to capture every available dollar to reduce their overall healthcare expenditures. One way to realize value is…
